[A step-by-step guide for safe off-label prescribing].

Area of Science:

• Medical Law and Ethics
• Pharmacology
• Clinical Practice Guidelines

Background:

• Existing Dutch legislation, including the Medicines Act and Medical Treatment Contracts Act (WGBO), provides the legal basis for off-label prescribing.
• Professional guidelines supplement the legal framework but are not fully integrated into routine clinical practice.
• A gap exists between the legal requirements for off-label drug use and its practical implementation by healthcare professionals.

Purpose of the Study:

• To develop and describe a practical, step-by-step guide for responsible off-label prescribing.
• To assist physicians in meeting regulatory requirements for off-label drug prescriptions.
• To ensure patient safety by promoting informed decision-making regarding off-label medication use.

Main Methods:

• Development of a stepwise protocol for evaluating and implementing off-label drug prescriptions.
• Focus on balancing unmet medical needs and alternative treatments against potential risks and benefits.
• Emphasis on clear patient information and consent processes.

Main Results:

• The guide provides a structured approach to off-label prescribing, ensuring deliberate consideration of all relevant factors.
• It facilitates compliance with legal and regulatory obligations for off-label drug use.
• The protocol enhances the quality of information provided to patients regarding off-label treatments.

Conclusions:

• A practical, step-by-step guide is essential for embedding legal requirements into daily practice for off-label prescribing.
• Improved information dissemination and professional consensus on patient consent are needed for more effective off-label use.
• This guide empowers physicians to prescribe off-label responsibly, prioritizing patient well-being and legal adherence.